ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS

• 收藏
• 分享

专利权人:

Neurodyn Life Sciences Inc.

发明人:

Alfred MAELICKE

申请号：

US16287413

公开号：

US20190262352A1

申请日:

2019.02.27

申请国别(地区):

US

年份:

2019

代理人:

摘要：

A method of treating a subject for a brain disease associated with cognitive impairment, including administering to a subject a chemical substance according to GLN-1062 or salt thereof:wherein the treatment includes transmucosal administration of a therapeutically effective amount of GLN 1062 or salt thereof in the oral cavity of the subject.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/